Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Ischemic Heart Disease

Free Subscription Articles published in Cardiovasc Res Retrieve available abstracts of 55 articles: HTML format

Single Articles

November 2025
1. HE M, Tay WT, Song N, Liu T, et al
   Cardioprotective role of RBFox1 in myocardial infarction-induced heart failure.
   Cardiovasc Res. 2025 Nov 26:cvaf206. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. CHEN Q, Liu J, Madonna R, Li F, et al
   Vasostatin-2 attenuates injury-induced neointimal hyperplasia through the ACE2/MasR/PPARgamma/NR1D1/Gas1 axis.
   Cardiovasc Res. 2025;121:2260-2277.
   PubMed     Abstract available
   
   
   
3. TAYLOR DJ, Saxton H, Xu X, Yones E, et al
   Invasive validation of novel 1D models for computation of coronary fractional flow reserve.
   Cardiovasc Res. 2025;121:2233-2245.
   PubMed     Abstract available
   
   
   
4. ZHANG Y, Dong Q, Bian X, Qiao Z, et al
   Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.
   Cardiovasc Res. 2025 Nov 12:cvaf223. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. BUGIARDINI R, Rahaman T, Manfrini O, Maas A, et al
   Diet and sex inequities in ischemic heart disease mortality across Europe: findings from the global burden of disease study.
   Cardiovasc Res. 2025 Nov 3:cvaf176. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2025
6. NOONAN J, Prijaya SA, Bienvenu LA, Dayawansa NH, et al
   CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion.
   Cardiovasc Res. 2025 Oct 3:cvaf165. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2025
7. GOLFOROUSH P, Sulaiman E, He D, Yellon DM, et al
   An activator of phosphatidylinositol 3-kinase alpha restores cardioprotection from ischaemia/reperfusion injury in mice with coronary atherosclerosis or insulin resistance.
   Cardiovasc Res. 2025;121:1722-1733.
   PubMed     Abstract available
   
   
   
8. REILLY-O'DONNELL B, Ferraro E, Brody R, Tikhomirov R, et al
   Protective effect of ursodeoxycholic acid upon the post-myocardial infarction heart.
   Cardiovasc Res. 2025 Sep 12:cvaf133. doi: 10.1093.
   PubMed    
   
   
   August 2025
9. VOLPE M, Gallo G, Guzik TJ, Williams B, et al
   Blood pressure management in secondary prevention after myocardial infarction.
   Cardiovasc Res. 2025 Aug 26:cvaf145. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. HADAYA J, Boukens BJD, Janse MJ, Cha S, et al
    Right stellate ganglion stimulation modulates arrhythmogenesis in acute left lateral ventricular ischaemia.
    Cardiovasc Res. 2025;121:1385-1391.
    PubMed     Abstract available
    
    
    
11. GUTMANN C, Barwari T, Schulte C, Theofilatos K, et al
    Platelets and inflammation-insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial.
    Cardiovasc Res. 2025;121:1392-1406.
    PubMed     Abstract available
    
    
    
12. STAPMANNS P, Abdelwahed YS, Wolfram C, Strassler E, et al
    Novel flow cytometry-based method for isolating and characterizing human coronary artery endothelial cells from catheter wires in coronary disease and microvascular dysfunction.
    Cardiovasc Res. 2025 Aug 9:cvaf139. doi: 10.1093.
    PubMed    
    
    
    July 2025
13. LARSSON I, Sun J, Ahmad S, Bergstrom G, et al
    Low-fibre diet is associated with high-risk coronary plaque features.
    Cardiovasc Res. 2025;121:1204-1214.
    PubMed     Abstract available
    
    
    
14. ABALLO TJ, Bae J, Paltzer WG, Chapman EA, et al
    Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration.
    Cardiovasc Res. 2025;121:1240-1253.
    PubMed     Abstract available
    
    
    June 2025
15. NGUYEN TQ, Vlasenko D, Shetty AN, Zhao E, et al
    Systematic review and meta-analysis of respiratory viral triggers for acute myocardial infarction and stroke.
    Cardiovasc Res. 2025 Jun 17:cvaf092. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. MYLONAS N, Siokatas G, Zacharia E, Pol C, et al
    Cardiac ischaemia/reperfusion in pigs and mice increases cardiomyocyte Kruppel-like factor 5 that aggravates tissue injury and remodelling.
    Cardiovasc Res. 2025;121:900-914.
    PubMed     Abstract available
    
    
    
17. ZHANG S, Xiang B, Zhao Y, Wang W, et al
    Single-cell epigenomic and transcriptomic analysis unveils the pivotal role of GATA5/ISL1+ fibroblasts in cardiac repair post-myocardial infarction.
    Cardiovasc Res. 2025 Jun 3:cvaf101. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
18. CHEN Q, Yu Y, Tong L, Weiss RM, et al
    Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling.
    Cardiovasc Res. 2025;121:760-774.
    PubMed     Abstract available
    
    
    
19. TALABIEKE S, Yang X, Yang J, Wan Q, et al
    Arachidonic acid synergizes with aspirin preventing myocardial ischaemia-reperfusion injury and mitigates bleeding risk.
    Cardiovasc Res. 2025;121:775-787.
    PubMed     Abstract available
    
    
    April 2025
20. AHMAD H, Gopakumar J, Nachun DC, Ma L, et al
    Single cell RNA sequencing of haematopoietic cells in fresh and frozen human atheroma tissue.
    Cardiovasc Res. 2025;121:396-404.
    PubMed     Abstract available
    
    
    
21. BONACINA F, Carnevale D
    Sleep protects the heart after myocardial infarction through a neuro-immune axis: time to implement healthy sleep for cardiovascular prevention?
    Cardiovasc Res. 2025 Apr 23:cvaf073. doi: 10.1093.
    PubMed    
    
    
    
22. DARWESH AM, Fang L, Altamimi TR, Jamieson KL, et al
    Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3.
    Cardiovasc Res. 2025;121:267-282.
    PubMed     Abstract available
    
    
    
23. ZHANG W, Zhang Y, Han L, Bo T, et al
    Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase.
    Cardiovasc Res. 2025;121:353-366.
    PubMed     Abstract available
    
    
    
24. ROSLAN A, Paulus K, Yang J, Matt L, et al
    Slack K+ channels confer protection against myocardial ischaemia/reperfusion injury.
    Cardiovasc Res. 2025;121:174-189.
    PubMed     Abstract available
    
    
    
25. DALKARA T, Ostergaard L, Heusch G, Attwell D, et al
    Pericytes in the brain and heart: functional roles and response to ischaemia and reperfusion.
    Cardiovasc Res. 2025;120:2336-2348.
    PubMed     Abstract available
    
    
    February 2025
26. CHEN M, Zhao N, Shi W, Xing Y, et al
    Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice.
    Cardiovasc Res. 2025 Feb 10:cvaf005. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. SHANG R, Rodrigues B
    Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following myocardial infarction.
    Cardiovasc Res. 2025 Feb 4:cvaf006. doi: 10.1093.
    PubMed    
    
    
    January 2025
28. VILAHUR G, Ben-Aicha S, Gutierrez M, Radike M, et al
    Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction.
    Cardiovasc Res. 2025 Jan 3:cvae264. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
29. FABIN N, Cenko E, Bergami M, Yoon J, et al
    Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age.
    Cardiovasc Res. 2024;120:2064-2077.
    PubMed     Abstract available
    
    
    
30. TANG XL, Wysoczynski M, Gumpert AM, Solanki M, et al
    Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy.
    Cardiovasc Res. 2024;120:1939-1952.
    PubMed     Abstract available
    
    
    
31. TAN J, Min J, Jiang Y, Liu S, et al
    CircCHSY1 protects hearts against ischaemia/reperfusion injury by enhancing heme oxygenase 1 expression via miR-24-3p.
    Cardiovasc Res. 2024;120:1924-1938.
    PubMed     Abstract available
    
    
    November 2024
32. AHERRAHROU R, Reinberger T, Hashmi S, Erdmann J, et al
    GWAS breakthroughs: mapping the journey from one locus to 393 significant coronary artery disease associations.
    Cardiovasc Res. 2024;120:1508-1530.
    PubMed     Abstract available
    
    
    
33. PAN Z, Lv J, Zhao L, Xing K, et al
    CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages.
    Cardiovasc Res. 2024;120:1531-1549.
    PubMed     Abstract available
    
    
    
34. ZHANG LJ, Hu YX, Huang RZ, Xu YY, et al
    Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition.
    Cardiovasc Res. 2024;120:1622-1635.
    PubMed     Abstract available
    
    
    October 2024
35. WANG YJ, Matter CM
    Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition.
    Cardiovasc Res. 2024;120:1369-1371.
    PubMed    
    
    
    
36. BAUMGARDT SL, Fang J, Fu X, Liu Y, et al
    Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
    Cardiovasc Res. 2024;120:1456-1471.
    PubMed     Abstract available
    
    
    September 2024
37. YANG R, Ruan B, Wang R, Zhang X, et al
    Cardiomyocyte betaII spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory function.
    Cardiovasc Res. 2024;120:1312-1326.
    PubMed     Abstract available
    
    
    
38. HEIANZA Y, Wang X, Kou M, Tiwari S, et al
    Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease.
    Cardiovasc Res. 2024 Sep 7:cvae199. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
39. PSALTIS PJ, Nguyen MT, Singh K, Sinhal A, et al
    Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction.
    Cardiovasc Res. 2024 Aug 27:cvae191. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. VAN OORTMERSSEN JAE, Ntlapo N, Tilly MJ, Bramer WM, et al
    Burden of risk factors in women and men with unrecognised myocardial infarction: a systematic review and meta-analysis.
    Cardiovasc Res. 2024 Aug 27:cvae188. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
41. HU M, Zhang X, Hu C, Ma ZG, et al
    Isthmin-1 alleviates cardiac ischaemia/reperfusion injury through cGMP-PKG signalling pathway.
    Cardiovasc Res. 2024;120:1051-1064.
    PubMed     Abstract available
    
    
    
42. KUFAZVINEI TTJ, Chai J, Boden KA, Channon KM, et al
    Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes.
    Cardiovasc Res. 2024 Jul 19:cvae142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. COLEMAN JA, Doste R, Ashkir Z, Coppini R, et al
    Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
    Cardiovasc Res. 2024;120:914-926.
    PubMed     Abstract available
    
    
    
44. FU L, Du J, Furkert D, Shipton ML, et al
    Depleting inositol pyrophosphate 5-InsP7 protected the heart against ischaemia-reperfusion injury by elevating plasma adiponectin.
    Cardiovasc Res. 2024;120:954-970.
    PubMed     Abstract available
    
    
    June 2024
45. PHAM QH, Bui TVA, Sim WS, Lim KH, et al
    Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischemic heart disease.
    Cardiovasc Res. 2024 Jun 8:cvae128. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. GRECO CM, Nisoli E
    The ketogenic diet is unable to improve cardiac function in ischemic heart failure: an unexpected result?
    Cardiovasc Res. 2024 Jun 6:cvae126. doi: 10.1093.
    PubMed    
    
    
    May 2024
47. SUGIYAMA T, Jang IK
    Is cutting-edge imaging technology superior to conventional angiography in improving outcomes of coronary artery stenting?
    Cardiovasc Res. 2024;120:e17-e19.
    PubMed    
    
    
    
48. HO KL, Karwi Q, Wang F, Wagg C, et al
    The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischemic heart failure.
    Cardiovasc Res. 2024 May 1:cvae092. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
49. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    PubMed     Abstract available
    
    
    
50. SUN Q, Chen W, Wu R, Tao B, et al
    Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction.
    Cardiovasc Res. 2024 Apr 26:cvae075. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
51. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    PubMed    
    
    
    
52. DE WIT S, Geerlings L, Shi C, Dronkers J, et al
    Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
    Cardiovasc Res. 2024 Feb 24:cvae038. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. TORIMOTO K, Elliott K, Nakayama Y, Yanagisawa H, et al
    Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with myocardial infarction and other cardiovascular diseases.
    Cardiovasc Res. 2024 Feb 23:cvae044. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
54. ABOULEISA RRE, Tang XL, Ou Q, Salama AM, et al
    Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats.
    Cardiovasc Res. 2024 Jan 4:cvae002. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
55. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.